Pertranquil

Pertranquil Brand names, Pertranquil Analogs

Pertranquil Brand Names Mixture

No information avaliable

Pertranquil Chemical_Formula

C₂₀H₂₃NS

Pertranquil RX_link

No information avaliable

Pertranquil fda sheet

Pertranquil msds (material safety sheet)

Pertranquil Synthesis Reference

No information avaliable

Pertranquil Molecular Weight

309.469 g/mol

Pertranquil Melting Point

< 25 ^oC

Pertranquil H₂O Solubility

Soluble as HCl salt

Pertranquil State

Liquid

Pertranquil LogP

5.7

Pertranquil Dosage Forms

Tablets (oral, 1 mg)

Pertranquil Indication

Used for the symptomatic treatment of parkinsonism.

Pertranquil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Pertranquil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Pertranquil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Pertranquil Patient Information

Pertranquil Organisms Affected

Humans and other mammals